What’s New with PARP Inhibitors and Ovarian Cancer?

Описание к видео What’s New with PARP Inhibitors and Ovarian Cancer?

PARP inhibitors have revolutionized ovarian cancer treatment, but recent updates to the FDA-approved indications have caused confusion and raised questions for patients. So what do these changes mean? Dr. Thomas Herzog, Deputy Director of the University of Cincinnati Cancer Center, discusses the current landscape of PARP inhibitors for ovarian cancer and what it means for you.

Комментарии

Информация по комментариям в разработке